Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Protease-activated receptor-2 (PAR2), which belongs to a specific class of the G-protein-coupled receptors, is central to several inflammation processes. However, the precise molecular mechanism involved remains undefined. Autophagy has been previously shown to affect inflammation. In the present study, we examine the effect of PAR2 on kidney tubular epithelial autophagy and on autophagy-related inflammation and reveal the underlying mechanism involved. Autophagic activity and levels of autophagic marker LC3 were examined in human kidney tubular epithelial cells with PAR2 knockdown or overexpression. We administered the mammalian target of rapamycin (mTOR) inhibitor (rapamycin) or activator (MHY1485) to investigate the function of the phosphoinositide 3-kinase (PI3K)/Akt/mTOR pathway. We also used transforming growth factor-β1 (TGF-β1)-induced HK-2 cell inflammation models to investigate the role of PAR2-associated autophagy in kidney tubular epithelial inflammation. PAR2 antagonist and rapamycin were administered to mice after unilateral ureteral obstruction to detect the correlations between PAR2, autophagy, and inflammation. Our results show that PAR2 overexpression in HK-2 cells led to a greater reduction in autophagy via the PI3K/Akt/mTOR pathway activation and induces autophagy-related inflammation. Meanwhile, a knockdown of PAR2 via PAR2 RNAi transfection greatly increased autophagy and alleviated autophagy-associated inflammation. In unilateral ureteral obstruction (UUO) kidneys, PAR2 antagonist treatment greatly attenuated renal inflammation and interstitial injury by enhancing autophagy. Moreover, inhibition of mTOR, rapa, markedly increased autophagy and inhibited the UUO-induced inflammation. We conclude that PAR2 induces kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway. Our results are suggestive that PAR2 inhibition may play a role in the treatment of diseases with increased inflammatory responses in renal systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, PAR-2 was shown to decrease autophagy through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway in kidney cells [ 108 , 109 ].”
From Melanin's Journey from Melanocytes to Keratinocytes: Uncovering the Molecular Mechanisms of Melanin Transfer and Processing (2023) · cites this paper as [108]
Citations
Cites
1 retracted
Zhou, S., Zhou, Z.-W., Li, X.-X., He, Z., Pan, S., Yang, Y.-X., Zhang, X., Chew, K., Yang, T., Qiu, J., et al. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s75976 · Cited by 103
RetractedAnalysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Methods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Autophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230
Autophagosome formation: core machinery and adaptations
Xie, Z., & Klionsky, D. J. (2007) · Nature Cell Biology · doi:10.1038/ncb1007-1102 · Cited by 2,164
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204
Cited by
Innate immunity in diabetic kidney disease
Tang, S. C. W., & Yiu, W. H. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0234-4 · Cited by 596
Melanin Transfer in the Epidermis: The Pursuit of Skin Pigmentation Control Mechanisms
Moreiras, H., Seabra, M. C., & Barral, D. C. (2021) · doi:10.20944/preprints202104.0441.v1 · Cited by 147
Melanin Transfer in the Epidermis: The Pursuit of Skin Pigmentation Control Mechanisms
Moreiras, H., Seabra, M. C., & Barral, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094466 · Cited by 145
“Additionally, in kidney tubular epithelial cells, PAR-2 activation was shown to inhibit autophagy via PI3K/Akt/mTOR signaling pathway [65].”
BackgroundPacker, M. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020010010 · Cited by 123
Bento-Lopes, L., Cabaço, L. C., Charneca, J., Neto, M. V., Seabra, M. C., & Barral, D. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411289 · Cited by 114
Mazzierli, T., Allegretta, F., Maffini, E., & Allinovi, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1088031 · Cited by 88
The role of PI3K/Akt signaling pathway in chronic kidney disease
Wang, H., Gao, L., Zhao, C., Fang, F., Liu, J., Wang, Z., Zhong, Y., & Wang, X. (2024) · International Urology and Nephrology · doi:10.1007/s11255-024-03989-8 · Cited by 97
“However, when this signal pathway is inhibited, autophagy can be resumed to alleviate renal injury [87].”
Lei, L., Zhao, J., Liu, X., Chen, J., Qi, X., Xia, L., & Wu, Y. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s310882 · Cited by 88
“The mTOR, mainly mediated by PI3K/Akt signaling transduction, can negatively regulate autophagy.(24) In diabetic patients, a large amount of undis-”
BackgroundXie, T., Xu, Q., Wan, H., Xing, S., Chen, S., Gao, Y., & He, Z. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0160-2 · Cited by 50
Role of renal tubular programed cell death in diabetic kidney disease
Zhou, X., Xu, C., Dong, J., & Liao, L. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3596 · Cited by 50
“contrast, the inhibition of PI3K/AKT/mTOR signalling initiated autophagic activity and protected against tubular epithelial injury.(83) Wang et al.”
BackgroundMeng, Q., Pu, L., Lu, Q., Wang, B., Li, S., Liu, B., & Li, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108096 · Cited by 45
Meng, Q., Pu, L., Qi, M., Li, S., Sun, B., Wang, Y., Liu, B., & Li, F. (2022) · Communications Biology · doi:10.1038/s42003-022-03392-y · Cited by 43
Hill, C. N., Hernández‐Cáceres, M. P., Asencio, C., Torres, B. M., Solis, B., & Owen, G. I. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.605314 · Cited by 39
“epithelial cells that PAR2 acting through the PI3K/AKT/mTOR pathway suppressed the process of autophagy, by affecting ATG5 and ATG12, and thus decreasing autophagosome formation (24).”
BackgroundHuang, T., Cao, Y., Wang, H., Wang, Q., Ji, J., Sun, X., & Dong, Z. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15142 · Cited by 35
Feng, H., Zhou, P., Liu, F., Zhang, W., Yang, H., Li, X., & Dong, J. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-26166-3 · Cited by 35
Kang, X., Jing, M., Zhang, G., Lan-zheng, H., Hong, P., & Deng, C. (2019) · Marine Drugs · doi:10.3390/md17040227 · Cited by 31
Ha, S., Chung, K. W., Lee, J., Chung, H. Y., & Moon, H. R. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01375-5 · Cited by 34
Huang, L., Lin, M., Zhong, X., Yang, H., & Deng, M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9824 · Cited by 39
“…cell death and survival (34). mTOR, which functions downstream of Akt, is mainly mediated by phosphoinositide 3-kinase/Akt signaling transduction and suppresses autophagy (35); therefore, the present study used the classic mTOR inhibitor rapamycin to investigate the effects of mTOR on autophagy.”
Zhuang, J., Nie, G., Yang, F., Cao, H., Xing, C., Dai, X., Hu, G., & Zhang, C. (2019) · Poultry Science · doi:10.3382/ps/pez477 · Cited by 28
“Many studies have found that autophagy is involved and regulated by multiple signaling pathways (Du et al., 2017; Huang et al., 2017; Luo et al., 2018).”
BackgroundWu, X., Pu, L., Chen, W., Zhao, Q., Wu, G., Li, D., & Zhu, H. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2055565 · Cited by 30
Ha, S., Yang, Y., Kim, B. M., Kim, J., Son, M., Kim, D., Yu, H. S., Im, D., Chung, H. Y., & Chung, K. W. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166474 · Cited by 28
Tissue Factor, Thrombosis, and Chronic Kidney Disease
Oe, Y., & Takahashi, N. (2022) · Biomedicines · doi:10.3390/biomedicines10112737 · Cited by 35
Bagang, N., Gupta, K., Singh, G., Kanuri, S. H., & Mehan, S. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110470 · Cited by 33
Zhuang, L., Jin, G., Hu, X., Yang, Q., & Shi, Z. (2019) · Europe PMC (PubMed Central) · Cited by 34
Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer
Wang, Y., Wu, N., & Jiang, N. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04181-x · Cited by 30
Yan, S., Ding, H., Junyang, P., Wang, X., Pang, C., Wei, J., Wei, J., & Chen, H. (2020) · Bioscience Reports · doi:10.1042/bsr20192620 · Cited by 24
Oe, Y., Miyazaki, M., & Takahashi, N. (2021) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.255.1 · Cited by 31
“Similarly, the therapeutic effects of PAR2 inhibition in kidney injuries were accompanied by a reduction in inflammation in the kidneys (Hayashi et al. 2016; Du et al. 2017; Han et al. 2019; Watanabe et al. 2019).”
BackgroundAutophagy in renal fibrosis: Protection or promotion?
Dai, R., Zhang, L., Jin, H., Wang, D., Cheng, M., Sang, T., Peng, C., Li, Y., & Wang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.963920 · Cited by 28
“It has been reported that SK1 expression induces autophagy activation and protects the kidney during fibrosis (Du et al., 2017a).”
BackgroundInfluentialChung, S., Son, M., Chae, Y., Oh, S., Koh, E. S., Kim, Y. K., Shin, S. J., Park, C. W., Jung, S., & Kim, H. (2021) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.20.264 · Cited by 23
Zhu, J., Qiu, J.-G., Xu, W.-T., Ma, H.-X., & Ke, J. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab091 · Cited by 21
Xiao, Q. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2056485 · Cited by 23
“The PI3K/Akt signaling pathway, acting as the upper stream of mTOR, participates in the modulation of autophagy, and kidney tubular epithelial inflammation can be induced by protease-activated receptor-2 via the PI3K/Akt/mTOR pathway activationinhibited autophagy [53].”
RetractedHer, J. Y., Lee, Y., Kim, S. J., Heo, G., Choo, J., Kim, Y., Howe, C. S., Rhee, S. H., Yu, H. S., Chung, H. Y., et al. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00203.2020 · Cited by 23
Cui, S., Zhou, Z., Liu, X., Richards, R. G., Alini, M., Peng, S., Liu, S., Zou, X., Li, Z., & Grad, S. (2020) · Diagnostics · doi:10.3390/diagnostics10121063 · Cited by 20
“The PI3K/Akt pathway was found to be involved in inflammation by interaction with the mTOR pathway [61,62].”
BackgroundMa, Y., Zhang, Y., Qiu, C., He, C., He, T., Shi, S., & Liu, Z. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.739212 · Cited by 19
“According to previous studies, PAR2 promoted activation of phosphoinositide 3-kinase (PI3K)/Akt signaling pathway which was related to a wide range of cellular biological processes (25).”
BackgroundDuan, Y., Zhang, D., Yan, Y., Zheng, S., Huang, P., Zhang, F., Mo, G., Huang, F., Yin, Q., Li, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.765563 · Cited by 19
“Besides, autophagy substantially reduced renal inflammation and interstitial damage in a unilateral ureteral obstruction (UUO) model where mTOR inhibition significantly increased autophagy and suppressed UUO-induced inflammation (Du et al., 2017).”
BackgroundJing, G.-H., Liu, Y.-D., Liu, J., Jin, Y., Yu, S., & An, R.-H. (2022) · Urolithiasis · doi:10.1007/s00240-022-01347-w · Cited by 17
“The AKT and p38 pathways have been reported to play pivotal roles in autophagy induction [16, 26].”
BackgroundLuo, H., Huang, Q., Huang, D., Liu, C., Long, X., & Tang, R.-G. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00089 · Cited by 15
Sui, X., Xie, T., Xu, Y., Zhang, A., Zhang, Y., Gu, F., Li, L., Xu, Z., & Chen, J. (2023) · Mediators of Inflammation · doi:10.1155/2023/5007488 · Cited by 18
Li, B., Li, Y., Li, S., Li, H., Liu, L., & Xu, Y. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s343864 · Cited by 12
Ha, S., Son, M., Kim, J., Kim, D., Kim, M., Yoo, J., Kim, B. M., Kim, D., Chung, H. Y., & Chung, K. W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031358 · Cited by 16
Melanin processing by keratinocytes: A non-microbial type of host-pathogen interaction?
Moreiras, H., Lopes‐da‐Silva, M., Seabra, M. C., & Barral, D. C. (2019) · Traffic · doi:10.1111/tra.12638 · Cited by 10
Molecular mechanisms and physiological functions of autophagy in kidney diseases
Yang, J., Yuan, L., Liu, F., Li, L., Liu, J., Chen, Y., Lu, Y., & Yuan, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.974829 · Cited by 14
Li, Z., Jiang, W., Chu, H., Ge, J., Wang, X., Jiang, J., Xiao, Q., Meng, Q., Hao, W., & Wei, X. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155357 · Cited by 10
Jung, H. J., An, H., Gwon, M., Gu, H., Bae, S., Lee, S.-J., Kim, Y.-A., Leem, J., & Park, K. (2022) · Molecules · doi:10.3390/molecules27030766 · Cited by 10
“Autophagy also clears other cellular components, such as cytokines, and serves as an important tool for regulating inflammation [41].”
BackgroundDysregulated coagulation system links to inflammation in diabetic kidney disease
Xiao, M., Tang, D., Luan, S., Hu, B., Gong, W., Pommer, W., Dai, Y., & Yin, L. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1270028 · Cited by 9
Huang, P., Yang, Z., Wang, H., Wang, C., Luo, M., Zhou, R., & Pan, Y. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03559-z · Cited by 14
Fan, L., Guo, Y., Wu, Q., Hu, T., Chen, X., Guo, J., Liu, Y., Lu, Y., & Lin, M. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/6931644 · Cited by 9
Villano, G., & Pontisso, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1397441 · Cited by 8
Proteinase-activated Receptor 2: Springboard of Tumors
Větvička, D., Šuhaj, P., Olejár, T., Sivák, L., Beneš, J., & POUCKOVA, P. (2023) · Anticancer Research · doi:10.21873/anticanres.16782 · Cited by 8
“Only limited efforts were made to investigate the connection between autophagy and PAR signalling in inflammation (62).”
BackgroundRen, B., Liu, H., Yang, Y., & Lian, Y. (2021) · Oncology Letters · doi:10.3892/ol.2021.12845 · Cited by 7
“The pathway is regulated by tyrosine kinase receptors, such as epidermal growth factor receptor 1‐2 and insulin‐like growth factor 1, which are indispensable for maintaining tumor cell proliferation, forming independent clones and distant invasion (21,22).”
BackgroundShimizu, S., Fukuda, N., Chen, L., Matsumoto, T., Kaneda, A., Endo, M., Nishiyama, A., & Morioka, I. (2024) · Hypertension Research · doi:10.1038/s41440-024-01756-x · Cited by 7
Wang, Y., Deng, X., Wei, J., Yang, Z., Du, Y., Song, S., Shi, Y., & Wu, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299389 · Cited by 6
Self-citationLi, J., Zheng, D., Qi, S., Mao, C., & Jiang, Y. (2024) · Small · doi:10.1002/smll.202405593 · Cited by 10
Role of protease-activated receptor 2 in regulation of renin synthesis and secretion in mice
Thurner, L. R., & Höcherl, K. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01677-4 · Cited by 6
Rao, Z., Li, X., Zhang, X., Zeng, J., Wang, B., Yang, R., & Zeng, N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.824579 · Cited by 5
Whole transcriptome expression profiles in kidney samples from rats with hyperuricaemic nephropathy
Li, N., Amatjan, M., He, P., Meiwei, W., Yan, H., & Shao, X. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276591 · Cited by 6
“Previous studies have suggested that protease-activated receptor-2 can inhibit autophagy through the PI3K/Akt/mTOR signalling pathway, thus promoting renal tubular epithelial inflammation [61].”
BackgroundKitasato, L., Yamaoka‐Tojo, M., Iwaya, T., Murayama, Y., Ikeda, Y., Hashikata, T., Oikawa, J., Suzuki, M., Misawa, N., Kawashima, R., et al. (2024) · Journal of Vascular Research · doi:10.1159/000542419 · Cited by 5
“According to previous studies, both PAR1 and PAR2 promote activation of the PI3K/Akt pathway, which is related to a wide range of cellular biological processes [67, 68].”
Kanazawa, N., Iyoda, M., Tachibana, S., Matsumoto, K., Wada, Y., Suzuki, T., Iseri, K., & Shibata, T. (2020) · Kidney & Blood Pressure Research · doi:10.1159/000506286 · Cited by 5
Li, Y., Ao, J., Huang, X., Lu, H., Fu, H., Song, N., Xu, W., & Chen, J. (2021) · Physiological Reports · doi:10.14814/phy2.15099 · Cited by 3
“The diabetic mice were sacrificed by cervical dislocation, and the entire colon was removed and placed in Krebs solution with a carbonated mixture (95% O [Feldman & Schiller, 1983] and 5% CO2).”
BackgroundMethodAndo, M., Matsumoto, T., Kobayashi, S., Iguchi, M., Taguchi, K., & Kobayashi, T. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00987 · Cited by 3
Clinical value of thalidomide on kk-rat model through TNF-a mediated inflammation approach
Huang, M., Jie, D. U. A. N., Bin, Y. U., Zheng, S., Chen, Q., Lin, F., Zeng, N., & Ling, B. (2021) · Food Science and Technology · doi:10.1590/fst.06821 · Cited by 3
Bao, L., Shi, X., & Shao, Y. (2025) · Drugs · doi:10.1007/s40265-025-02221-w · Cited by 3
“Conversely, inhibition of PI3K/AKT/mTOR signaling initiates autophagy activity and protects renal tubular epithelium [81].”
Yazdanimoghaddam, F., Rezazadeh, H., Soltani, N., Mehranfard, N., Dastgerdi, A. H., Rad, M. G., & Ghasemi, M. (2024) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672924600386 · Cited by 1
Bagang, N., Gupta, K., Mehan, S., & Singh, G. (2021) · doi:10.22541/au.164081642.27222358/v1 · Cited by 1
Expression analysis of protease-activated receptor-2 in cats
Iio, A., Kaji, K., Kaji, N., Hori, M., Yonezawa, T., Momoi, Y., & Maeda, S. (2020) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2020.110115
Liu, Y., Jun-Ping, A., Huang, X. L., Li, H., Han-Yue, F., Ni-Na, S., Wen-xie, X., & Chen, J. (2021) · Japanese Journal of Gastroenterology and Hepatology · doi:10.47829/jjgh.2021.6205 · Cited by 1
“Previous evidence indicates that the binding of a PAR2 agonist to PAR2 stimulates the cell proliferation mediated the PI3K/Akt signaling pathway [28, 29].”
BackgroundLi, L., Wang, H., & Zhao, C. (2023) · Materials Express · doi:10.1166/mex.2023.2568
The critical roles of activated factor X in autophagy in the pathogenesis of atherosclerosis
Maejima, Y. (2024) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.35.688
Promsuwan, S., Takiyama, Y., Takiyama, T., Takiyama, Y., Kitsunai, H., & Nomoto, H. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70454
“…a convergence point for multiple upstream inputs 59 beyond insulin, including receptor tyrosine kinases (RTKs), G-protein coupled receptors (GPCRs), 60,61 angiotensin II, 59,62 integrin, 63 starvation stress, 64 and intracellular modulators such as phosphatidylinositol-3-kinase (PI3K), 65…”
Metadata
- Authors
- Du, C., Zhang, T., Xiao, X., Shi, Y., Duan, H., & Ren, Y.
- Affiliations
- Hebei Medical University (CN)
- Third Hospital of Hebei Medical University (CN)
- Corresponding author
- Ren, Yunzhuo
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2017-08-02
- Volume
- 474
- Issue
- 16
- Pages
- 2733-2747
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2735568802
- Cited by
- 68
- References
- 49
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 9 · 2023: 10 · 2022: 15 · 2021: 14 · 2020: 9 · 2019: 7 · 2018: 1
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2024-04-10)
- Open access
- closed
- Locations
- Biochemical Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hebei University
- Hebei Medical University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- protease-activated receptor 2, autophagy, PI3K/AKT/mTOR pathway, mTOR inhibition, rapamycin, HK-2 cells, unilateral ureteral obstruction, TGF-β1, LC3, G protein-coupled receptors
- MeSH terms
- Animals, Autophagy, Humans, Inflammation, Kidney, Phosphorylation, Signal Transduction, Apoptosis, Phosphatidylinositol 3-Kinases, Sirolimus, Receptor, PAR-2, Proto-Oncogene Proteins c-akt, Transforming Growth Factor beta1, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.